Literature DB >> 20690886

Targeting miRNAs in osteoblast differentiation and bone formation.

Rong Hu1, Hui Li, Wei Liu, Li Yang, Yan-Fei Tan, Xiang-Hang Luo.   

Abstract

IMPORTANCE OF THE FIELD: Bone tissue arises from mesenchymal stromal cells (MSCs) differentiated into the osteoblast lineage by genetic and epigenetic mechanisms. Emerging evidence indicates that the class of small non-coding single-stranded RNAs known as "microRNAs (miRNAs)" also plays a critical role in this process. AREAS COVERED IN THIS REVIEW: In this short review, we summarize the biology and functional mechanisms of miRNAs. Importantly, we discuss miRNA expression, miRNA function, miRNA target prediction, miRNA overexpression and inhibition methods applied in osteoblastogenesis. WHAT THE READER WILL GAIN: We discuss the potential therapeutic opportunities and challenges for improving the treatment of bone-related diseases by using miRNAs as a therapeutic target. TAKE HOME MESSAGE: Although various microRNAs regulate cell proliferation and differentiation, only a few miRNAs has been reported so far to play a key role in the regulation of osteoblast differentiation and bone formation.

Mesh:

Substances:

Year:  2010        PMID: 20690886     DOI: 10.1517/14728222.2010.512916

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  29 in total

1.  miR-125a-3p targetedly regulates GIT1 expression to inhibit osteoblastic proliferation and differentiation.

Authors:  Xiao-Mei Tu; Yang-Lin Gu; Guo-Qin Ren
Journal:  Exp Ther Med       Date:  2016-11-04       Impact factor: 2.447

2.  miR-141 modulates osteoblastic cell proliferation by regulating the target gene of lncRNA H19 and lncRNA H19-derived miR-675.

Authors:  Peiheng He; Ziji Zhang; Guangxin Huang; Hua Wang; Dongliang Xu; Weiming Liao; Yan Kang
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

3.  MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo.

Authors:  Tilde Eskildsen; Hanna Taipaleenmäki; Jan Stenvang; Basem M Abdallah; Nicholas Ditzel; Anne Yael Nossent; Mads Bak; Sakari Kauppinen; Moustapha Kassem
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

4.  Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.

Authors:  Magdalena Kozakowska; Krzysztof Szade; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

5.  Involvement of microRNA-23b in TNF-α-reduced BMSC osteogenic differentiation via targeting runx2.

Authors:  Lin Deng; Guoli Hu; Lei Jin; Chenglong Wang; Hongwen Niu
Journal:  J Bone Miner Metab       Date:  2017-12-12       Impact factor: 2.626

6.  Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Osteoporosis via MicroRNA-27a-Induced Inhibition of DKK2-Mediated Wnt/β-Catenin Pathway.

Authors:  Yan Wang; Xiaoqi Zhou; Dalin Wang
Journal:  Inflammation       Date:  2021-10-21       Impact factor: 4.092

7.  Methionine-Restricted Diet Increases miRNAs That Can Target RUNX2 Expression and Alters Bone Structure in Young Mice.

Authors:  Jason Plummer; Miri Park; Frantz Perodin; Mark C Horowitz; Julie R Hens
Journal:  J Cell Biochem       Date:  2016-06-22       Impact factor: 4.429

8.  Silk Biomaterials-Mediated miRNA Functionalized Orthopedic Devices.

Authors:  Eric N James; Emily Van Doren; Chunmei Li; David L Kaplan
Journal:  Tissue Eng Part A       Date:  2018-08-22       Impact factor: 3.845

9.  Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1.

Authors:  Woochul Chang; Chang Youn Lee; Jun-Hee Park; Moon-Seo Park; Lee-So Maeng; Chee Soon Yoon; Min Young Lee; Ki-Chul Hwang; Yong-An Chung
Journal:  J Vet Sci       Date:  2013-02-05       Impact factor: 1.672

10.  Identification and characterization of microRNAs controlled by the osteoblast-specific transcription factor Osterix.

Authors:  Qin Chen; Wenbin Liu; Krishna M Sinha; Hideyo Yasuda; Benoit de Crombrugghe
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.